All In Biotech

Free tool

FAERS Monitor: Signifor Lar Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203255 or its brand name (Signifor Lar Kit, Pasireotide Pamoate). Reports on generic versions are filed under their own applications.

Reports

1,502

Serious

1,066

71% of reports

Hospitalization

452

Death reported

103

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased169
  • diabetes mellitus165
  • hyperglycaemia163
  • drug ineffective125
  • diarrhoea121
  • off label use120
  • headache117
  • fatigue105
  • nausea97
  • dizziness72
  • blood pressure increased69
  • asthenia60
  • vomiting60
  • weight decreased58
  • glycosylated haemoglobin increased56

Reports by year received

View as table
YearReports
20111
20121
20136
201421
201560
2016139
2017138
2018138
2019128
2020175
202196
2022124
2023157
2024136
2025118
202664

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,657 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperglycaemiaSignal16362.954.49,844
glycosylated haemoglobin increasedSignal5631.124.11,602
diabetes mellitusSignal16530.426.34,664
blood glucose increasedSignal16912.610.91,803
blood pressure increasedSignal696.35.0306
weight decreasedSignal582.92.372
diarrhoeaSignal1212.62.2124
headacheSignal1172.62.2118
astheniaSignal602.21.740
dizzinessSignal722.01.637
off label use1201.91.654
fatigue1051.91.645
vomiting601.81.420
nausea971.71.429
drug ineffective1251.31.110

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.